FundedIQ
Community and Lifestyle

IM Cannabis

IM Cannabis is a company that manufactures and disseminates medical marijuana. They provide various products for patients and conduct research to develop innovative genetic strains. IM Cannabis was established by Oren Shuster and Rafael Gabay in Glil Yam, Tel Aviv, in 2010.

imcannabis.com Glil Yam, Israel 251-500 employees
Total raised
$11.4M
Latest round: +10% of prior total
Rounds
5
Latest
Series Unknown
Jul 2025

IM Cannabis is a company that manufactures and disseminates medical marijuana. They provide various products for patients and conduct research to develop innovative genetic strains. IM Cannabis was established by Oren Shuster and Rafael Gabay in Glil Yam, Tel Aviv, in 2010.

IM Cannabis has raised $11.4M across 5 rounds. Its most recent round was a Series Unknown of $1.0M in Jul 2025. Full funding history, investors, and team are detailed below.

Funding history

5 rounds · 1 visible Unlock with plan

5 rounds on record — latest round shown, the rest unlock with a paid plan.

Date
Round
Amount
Lead investor
Jul 9, 2025
Series Unknown
$1.0M

Unlock 4 earlier rounds — dates, amounts, round types — plus the lead investor for every round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

IM Cannabis is featured in

Similar companies

FEMSelect

FEMSelect is revolutionizing women's health with their cutting-edge technology platform. They have developed EnPlace, a mesh-free system for pelvic floor ligament fixation that can be inserted in about 30 minutes. Their patented delivery system ensures accurate guidance, insertion, and deployment of the anchor unit, which is designed to stabilize the pelvic floor ligament after being secured through the vaginal wall. Founded in 2012, FEMSelect is based in Modi'in, Israel.

Series B
ELSE Nutrition

Else Nutrition offers plant-based nutrition products for the infant, toddler, children, and adult markets. It develops a plant-based non-soy alternative to dairy-based baby formula.

Series Unknown $350k
Jotit

Jotit is an innovative educational technology company that utilizes handwriting tools to assist children, teachers, and parents in remaining organized.

Seed $10.0M
ConTIPI Medical

ConTIPI Medical offers vaginal solutions that are disposable and non-surgical for women with various Pelvic Floor Disorders (PFD's). These solutions allow women to directly manage their condition and have already been successfully developed and brought to market. The Impressa Device, marketed by Kimberly Clark Inc. under the Poise® brand, is an example of this concept and is used for Stress Urinary Incontinence. ConTIPI Medical's second product, the ProVate Device, is intended for non-surgical management of Pelvic Organ Prolapse (POP) and has received a CE Mark for marketing in the EU. It is currently undergoing final clinical studies in the USA. Both devices are delivered in a wrapper and can be easily used at home. They are inserted vaginally using an applicator, which compresses them to a small size. Once inserted, the applicator deploys the device, providing support to specific areas along the vaginal walls. At the end of use, the device is removed with a pull of a string, reducing its size and then disposed of. These devices empower women to take control of their medical issues and use them in privacy and convenience. The ProVate device was specifically designed for women with Pelvic Organ Prolapse who prefer non-invasive management. Traditional pessaries have high discontinuation rates and many users are reluctant to use reusable devices that are difficult to insert and remove. The ProVate disposable device solves these issues by providing vaginal support that can be inserted and removed by the user at home.

Series Unknown $40.0M
daily.dev

The Daily Dev platform provides a community of developers with opportunities to expand their knowledge, work together, and advance in their careers.

Seed $11.0M
Crowdvocate

Crowdvocate helps B2B organizations draw in their clients consequently (trigger-based) all through their life-cycle, and enact them for different exercises like support, criticism, references, upsell, social enhancement, and that's just the beginning. Our omnichannel and in-application modules empower frictionless client cooperations at scale, and our use systems permit utilizing the voice of the clients (VOC) for business development. We give a self-serve device to B2B organizations to use their groups = their Customers, Partners, Eco-framework, and Employees, and prepare them to become brand advocates. Our vision is to empower organizations to encounter the best development strategy, at incredible ROI, through arranged and robotized informal. Crowdvocate increments references, references, item audits, positioning, reliability, client based lead age, swarm based content creation, ideation and considerably more.

Venture - Series Unknown $15.0M
Mindspace

Mindspace is a boutique flex space provider, presenting a global mindset with a local flavor. We redefine the workplace experience for companies of all sizes. Our beautifully designed spaces, personalized level of service and carefully curated events foster enhanced employee engagement and a strong sense of community, accommodating the way people work, innovate and grow. Our customer base includes blue-chip companies, enterprises and SMBs, in 31 locations, 16 cities and 7 countries across Europe and the US.

Venture - Series Unknown $72.0M
Noveto Systems

Noveto Systems produces focussed audio solutions, creating Virtual Headphones - Headphones without Headphones

$10.0M
Nabta Health

Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs. The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations. Moreover, NCDs leave populations more susceptible to communicable diseases such as coronaviruses, influenza and tuberculosis. During the COVID-19 pandemic of 2020, 78% of people admitted to ICU in the US and 94% of those who died had underlying health conditions (CDC). NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Only since 1994, when the United States’ National Institutes of Health (NIH) mandated that women and minorities were to be included as subjects in clinical research, has the research community entertained the fact that sex and/or gender differences might affect clinical outcomes. Today, women using drugs that were approved by the early 90s, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes. Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to achieve a formal diagnosis of PCOS within 90 days. The average time taken to diagnose PCOS currently is 2.5 years.

Seed $2.0M
TULU

TULU is the Usage Economy platform that elevates products and services brands to win today’s needs-driven consumers. We provide building tenants with on-demand access to hundreds of brand-name appliances, grocery staples, and micro-mobility and entertainment devices, in residential buildings, student housing, and offices. TULU’s IoT-based smart rental units are customized to provide the most necessary and useful items, while leveraging data to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. We are a global company with operations in 15 cities across the US and Europe, working with the largest landlords in the world, such as Greystar Real Estate Partners, Brookfield Asset Management, Invesco, RXR Realty and CA Ventures, and top brand manufacturers such as Bosch, Hoover, Kärcher and Unagi.

Series A $17.0M
Joy

A world of parenting resources in one place, so you can get the exact help you need to be the parent you want to be.

Series A $14.0M
CityLegends

CityLegends is a platform that brings together urban athletes and artists. It allows people to explore the urban world, connect with others, compete fiercely, and leave a lasting legacy. Our goal is to create a highly engaged community of urban athletes and artists and give them a platform to express their voices. LINES by CityLegends is an Urban Institute that supports policymakers, partners, and communities in the field of urban sports and culture. We create connections between partners, cities, governments, and alternative youth cultures through our digital urban platform, city dashboard, and urban creators. We are proud to have connected over 100,000 young citizens and reach millions of people every month. We also assist over 40 municipalities, brands, and governments in developing strategies to create active, social, and vibrant communities for young citizens. Our values include independence, being a forever community, supporting freedom, making voices heard, shaping cities, and most importantly, never being done.

Seed $2.0M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.